Kia ora

  

Thank you for your request for official information. The reference number
for your request is: H2024055740

  

As required under the Official Information Act 1982, The Ministry of
Health will endeavour to respond to your request no later than 20 working
days after the day your request was received. If you'd like to calculate
the timeframe, you can use the Ombudsman's online calculator
here: [1]http://www.ombudsman.parliament.nz/  

  

If you have any queries, please feel free to contact the OIA Services Team
on [2][email address]. If any additional factors come to light which
are relevant to your request, please do not hesitate to contact us so that
these can be taken into account.  

Under section 28(3) of the Act you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [3][email address] or by calling 0800
802 602.

 

Ngā mihi 

 

OIA Services Team 

[4]Ministry of Health information releases 

 

 

------------------- Original Message

show quoted sections

Tçnâ koe Yasir,  
 
Thank you for your request under the Official Information Act 1982 (the
Act) to the Ministry of Health-Manatû Hauora on 11 November 2024. 
  
The Ministry does not hold any information relating to the first two
questions of your request; 
"Funding Details: 
The total amount of taxpayer money allocated for the procurement and
distribution of puberty blockers in New Zealand over the past five years.
A breakdown of annual expenditures on puberty blockers during this
period."
However, I have been advised that this information is held by Health New
Zealand (Te Whatu Ora). For this reason, I have decided to transfer your
request to Health New Zealand under section 14(b)(i) of the Act. You can
expect a response to these questions from their agency in due course.
Their contact email is: [1][email address].
The Ministry will respond to the rest of your request in due course. 
  
Under section 28(3) of the Act, you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [2][email address] or by calling 0800
802 602. 

Ngâ mihi 

  

OIA Services Team

Manatû Hauora | Ministry of Health

M[3]inistry of Health information releases 

--------------------------------------------------------------------------

From: Yasir Shaikh <[FOI #29139 email]>
Sent: Monday, 11 November 2024 12:38
To: OIA Requests <[email address]>
Subject: Official Information request - Official Information Act Request –
Funding, Distribution, and Legal Framework of Puberty Blockers
 
Dear Ministry of Health,

Subject: Official Information Act Request – Funding, Distribution, and
Legal Framework of Puberty Blockers

Under the Official Information Act 1982, I respectfully request the
following information:

Funding Details:

The total amount of taxpayer money allocated for the procurement and
distribution of puberty blockers in New Zealand over the past five years.
A breakdown of annual expenditures on puberty blockers during this period.

Distribution in Educational Institutions:

Are puberty blockers administered or distributed within educational
institutions, including primary and secondary schools, as well as
colleges?
If so, please provide details on the policies and protocols governing
their administration in these settings.

Clinical Guidelines and Oversight:

What clinical guidelines does the Ministry of Health follow regarding the
prescription and administration of puberty blockers to minors?
What oversight mechanisms are in place to monitor the use of puberty
blockers among youth?

Adverse Effects and Reporting:

Have there been any reported adverse effects or complications associated
with the use of puberty blockers in minors over the past five years?
If so, please provide a summary of these reports and any actions taken in
response.
Informed Consent:

What processes are in place to ensure that minors and their guardians
provide informed consent before initiating treatment with puberty
blockers?

Legal Framework:

Since which year have puberty blockers been legally administered to the
public in New Zealand?
Under which laws or regulations are healthcare providers authorized to
prescribe and administer puberty blockers?

If any part of my request is unclear or requires further clarification,
please do not hesitate to contact me.

Thank you for your attention to this matter. I look forward to your
response within the statutory timeframe.

Yours sincerely,

Yasir Shaikh

-------------------------------------------------------------------

This is an Official Information request made via the FYI website.

Please use this email address for all replies to this request:
[FOI #29139 email]

Is [Ministry of Health request email] the wrong address for Official Information requests
to Ministry of Health? If so, please contact us using this form:
[4]https://aus01.safelinks.protection.outlo...

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[5]https://aus01.safelinks.protection.outlo...

If you find this service useful as an Official Information officer, please
ask your web manager to link to us from your organisation's OIA or LGOIMA
page.

show quoted sections

Kia ora Yasir,
Further to the below email, the Ministry is also transferring the below
questions to Health New Zealand - Te Whatu Ora to respond. As such you can
expect a response to these questions from their agency in due course.
Their contact email is: [1][email address].  
“"Funding Details:
The total amount of taxpayer money allocated for the procurement and
distribution of puberty blockers in New Zealand over the past five years.
A breakdown of annual expenditures on puberty blockers during this period.
Distribution in Educational Institutions
Are puberty blockers administered or distributed within educational
institutions, including primary and secondary schools, as well as
colleges?
If so, please provide details on the policies and protocols governing
their administration in these settings.
Clinical Guidelines and Oversight
What clinical guidelines does the Ministry of Health follow regarding the
prescription and administration of puberty blockers to minors?
What oversight mechanisms are in place to monitor the use of puberty
blockers among youth?
The Ministry will respond to the rest of your request in due course. 
Adverse Effects and Reporting:
Have there been any reported adverse effects or complications associated
with the use of puberty blockers in minors over the past five years?
If so, please provide a summary of these reports and any actions taken in
response.
Informed Consent:
What processes are in place to ensure that minors and their guardians
provide informed consent before initiating treatment with puberty
blockers?
Legal Framework:
Since which year have puberty blockers been legally administered to the
public in New Zealand?
Under which laws or regulations are healthcare providers authorized to
prescribe and administer puberty blockers?
Under section 28(3) of the Act, you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [2][email address] or by calling 0800
802 602.  

Ngâ mihi 

OIA Services Team

Manatû Hauora | Ministry of Health

M[3]inistry of Health information releases 

--------------------------------------------------------------------------

From: OIA Requests <[email address]>
Sent: Friday, 15 November 2024 15:47
To: Yasir Shaikh <[FOI #29139 email]>
Subject: Partial transfer of your request for official information, ref:
H2024055740 CRM:0121172
 
Tçnâ koe Yasir,  
 
Thank you for your request under the Official Information Act 1982 (the
Act) to the Ministry of Health-Manatû Hauora on 11 November 2024. 
  
The Ministry does not hold any information relating to the first two
questions of your request; 
"Funding Details: 
The total amount of taxpayer money allocated for the procurement and
distribution of puberty blockers in New Zealand over the past five years.
A breakdown of annual expenditures on puberty blockers during this
period."
However, I have been advised that this information is held by Health New
Zealand (Te Whatu Ora). For this reason, I have decided to transfer your
request to Health New Zealand under section 14(b)(i) of the Act. You can
expect a response to these questions from their agency in due course.
Their contact email is: [4][email address].
The Ministry will respond to the rest of your request in due course. 
  
Under section 28(3) of the Act, you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [5][email address] or by calling 0800
802 602. 

Ngâ mihi 

  

OIA Services Team

Manatû Hauora | Ministry of Health

M[6]inistry of Health information releases 

--------------------------------------------------------------------------

From: Yasir Shaikh <[FOI #29139 email]>
Sent: Monday, 11 November 2024 12:38
To: OIA Requests <[email address]>
Subject: Official Information request - Official Information Act Request –
Funding, Distribution, and Legal Framework of Puberty Blockers
 
Dear Ministry of Health,

Subject: Official Information Act Request – Funding, Distribution, and
Legal Framework of Puberty Blockers

Under the Official Information Act 1982, I respectfully request the
following information:

Funding Details:

The total amount of taxpayer money allocated for the procurement and
distribution of puberty blockers in New Zealand over the past five years.
A breakdown of annual expenditures on puberty blockers during this period.

Distribution in Educational Institutions:

Are puberty blockers administered or distributed within educational
institutions, including primary and secondary schools, as well as
colleges?
If so, please provide details on the policies and protocols governing
their administration in these settings.

Clinical Guidelines and Oversight:

What clinical guidelines does the Ministry of Health follow regarding the
prescription and administration of puberty blockers to minors?
What oversight mechanisms are in place to monitor the use of puberty
blockers among youth?

Adverse Effects and Reporting:

Have there been any reported adverse effects or complications associated
with the use of puberty blockers in minors over the past five years?
If so, please provide a summary of these reports and any actions taken in
response.
Informed Consent:

What processes are in place to ensure that minors and their guardians
provide informed consent before initiating treatment with puberty
blockers?

Legal Framework:

Since which year have puberty blockers been legally administered to the
public in New Zealand?
Under which laws or regulations are healthcare providers authorized to
prescribe and administer puberty blockers?

If any part of my request is unclear or requires further clarification,
please do not hesitate to contact me.

Thank you for your attention to this matter. I look forward to your
response within the statutory timeframe.

Yours sincerely,

Yasir Shaikh

-------------------------------------------------------------------

This is an Official Information request made via the FYI website.

Please use this email address for all replies to this request:
[FOI #29139 email]

Is [Ministry of Health request email] the wrong address for Official Information requests
to Ministry of Health? If so, please contact us using this form:
[7]https://aus01.safelinks.protection.outlo...

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[8]https://aus01.safelinks.protection.outlo...

If you find this service useful as an Official Information officer, please
ask your web manager to link to us from your organisation's OIA or LGOIMA
page.

show quoted sections

Tēnā koe, 

 

Thank you for contacting Health NZ, Te Whatu Ora. This is an automatic
reply to confirm that we have received your email.  Depending on the
nature of your request you may not receive a response for up to 20 working
days.  We will try to respond to your query as quickly as possible.

 

 

Ngā mihi

 

Health NZ, Te Whatu Ora.

Statement of confidentiality: This email message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege. If you are not the intended recipient, do not read, use,
disseminate, distribute or copy this message or attachments. If you have
received this message in error, please notify the sender immediately and
delete this message

Kia ora Yasir

 

Thank you for your request for the following information, partially
transferred by the Ministry of Health to Health New Zealand on 12 November
2024:

 

The total amount of taxpayer money allocated for the procurement and
distribution of puberty blockers in New Zealand over the past five years. 

 

Your request asks for information which is more closely aligned with the
functions of Pharmac. For this reason, Health New Zealand has decided to
transfer your request in full to Pharmac under section 14 of the Act. You
can expect a response from Pharmac in due course.

 

Under section 28(3) of the Act you have the right to ask the Ombudsman
to review any decisions made under this request. The Ombudsman may be
contacted by email at: [1][email address] or by calling 0800
802 602. If you have any queries related to this request, please do not
hesitate to get in touch.  

 

Nāku iti noa, nā 

 

 

Government Services Team

 

Statement of confidentiality: This email message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege. If you are not the intended recipient, do not read, use,
disseminate, distribute or copy this message or attachments. If you have
received this message in error, please notify the sender immediately and
delete this message

References

Visible links
1. mailto:[email address]

Kia ora Yasir,
Please find attached a response to your request for official information. 

Ngā mihi 

 

OIA Services Team

Manatū Hauora | Ministry of Health

M[1]inistry of Health information releases 

show quoted sections

References

Visible links
1. https://www.health.govt.nz/about-ministr...

Kia ora Yasir
 
Thank you for your request for information on 15 November 2024 regarding
puberty blockers.
 
Please find attached our response to your request.
 
If you have any questions, please get in touch at
[1][email address].
 
If you are not happy with this response, you have the right to make a
complaint to the Ombudsman. Information about how to do this is available
at [2]www.ombudsman.parliament.nz or by phoning 0800 802 602.
 
Ngā mihi
 

Joy

Government Services

 
 

Statement of confidentiality: This email message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege. If you are not the intended recipient, do not read, use,
disseminate, distribute or copy this message or attachments. If you have
received this message in error, please notify the sender immediately and
delete this message

References

Visible links
1. mailto:[email address]
2. file:///tmp/